New Alzheimer's drug slows cognitive decline – and may be available as early as next year

By Bernadette McGuinness, Clinical Professor of Ageing, Queen's University Belfast
Elizabeth Coulthard, Associate Professor in Dementia Neurology, University of Bristol

Lecanemab is the first drug to help improve the symptoms of Alzheimer’s by slowing the disease. These are very promising results, although the only data we have at the moment is from the drugmaker’s press release.

Lecanemab is an antibody that finds and removes a protein called amyloid that builds up and forms clumps in the brains of people with Alzheimer’s disease. By targeting amyloid, lecanemab is striking at the heart of the disease…

Read complete article

~	Indigenous women are most affected by domestic violence but have struggled to be heard. It’s time we listened

~	With Pause, US Joins Other States Stopping Arms Transfers to Israel

~	UN expert raises alarm over unfair treatment of pro-Palestinian student protesters in US

~	Germany: British-Palestinian Doctor Denied Schengen Entry

~	Love is the driving force behind the cries, the marches and the search for our disappeared loved ones

~	A jacket, a coin, a letter − relics of Omaha Beach battle tell the story of D-Day 80 years later

~	Lassa fever case in Paris: what you need to know

~	Mexico’s criminal gangs stir up political violence ahead of election season

~	AI system can predict the structures of life’s molecules with stunning accuracy – helping to solve one of biology’s biggest problems

~	I’ve spent decades overseeing relief operations around the world, and here’s what’s going wrong in Gaza